Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Esophageal Squamous Cell Carcinoma × abiraterone × Clear all

Sponsor

Conditions

Prostatic Neoplasms 21 Neoplasm Metastasis 2 Carcinoma, Non-Small-Cell Lung 2 Urogenital Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Prostatic Neoplasms, Castration-Resistant 1 Primary Myelofibrosis 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Newly Diagnosed Oligometastatic Prostate Cancer 1 Neoplasms 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Metastatic Castration-resistant Prostate Cancer 1 Metastatic Castration-Resistant Prostate Cancer 1 Metastatic Castration Resistant Prostate Cancer 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Leukemia 1 Glioblastoma 1 Colorectal Neoplasms 1 Carcinoma, Small Cell 1 Breast Neoplasms 1 Anus Neoplasms 1

Interventions

Radiotherapy 10 Cisplatin 9 Paclitaxel 8 pembrolizumab 7 Fluorouracil 7 Oxaliplatin 6 Irinotecan 6 Cetuximab 5 tislelizumab 4 Docetaxel 4 Radiation 3 Leucovorin 3 Carboplatin 3 Capecitabine 3 Nivolumab 2 Neoadjuvant Therapy 2 Immunohistochemistry 2 Biopsy 2 10-propargyl-10-deazaaminopterin 2 tremelimumab 1 sitravatinib 1 sintilimab 1 regorafenib 1 pegylated granulocyte colony-stimulating factor, human 1 pegfilgrastim 1 oblimersen 1 durvalumab 1 cixutumumab 1 adavosertib 1 Taxes 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡